SCHEMBL6246780

SCHEMBL6246780

CCOCn1cc(I)cn1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954658 0.79 DGAT1 (0.34)
SCHEMBL19015017 0.78
SCHEMBL1581682 0.77
SCHEMBL7260575 0.77 ALDH1A1 (0.41)
SCHEMBL17508623 0.77 MEN1 (0.42)
SCHEMBL671590 0.74
SCHEMBL26962749 0.73 NLRP3 (0.39)
SCHEMBL26388990 0.73
SCHEMBL24609489 0.72 FFAR1 (0.57)
SCHEMBL3768372 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157002-B1 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS USEFUL IN THERAPY PFIZER LTD (GB) 2005-08-10 EP disclosed
EP-1157002-A1 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS USEFUL IN THERAPY Pfizer Limited (GB) 2001-11-28 EP disclosed
WO-2000051972-A1 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS USEFUL IN THERAPY PFIZER LIMITED (GB) 2000-09-08 WO disclosed